Announcements Trials
Browse Landscape

Phase

Phase 4 11Phase 2 5Phase 1/2 2Phase 3 1Phase 2/3 1Phase 1 1

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 1

Conditions

Warts 1Uterine Cervical Dysplasia 1Infections 1Condylomata Acuminata 1

Interventions

pembrolizumab 409Cyclophosphamide 398Carboplatin 307Gemcitabine 286Nivolumab 276Paclitaxel 274Cisplatin 252Radiotherapy 225Dexamethasone 209Bevacizumab 207fludarabine 195Docetaxel 186Rituximab 183Capecitabine 171Oxaliplatin 158Lenalidomide 157Fluorouracil 152Temozolomide 138Cytarabine 135Etoposide 128Irinotecan 124Cetuximab 123fludarabine phosphate 121Injections 118venetoclax 116Ipilimumab 115Doxorubicin 114Azacitidine 108130-nm albumin-bound paclitaxel 108Pemetrexed 107

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Interventional × Human Papillomavirus Recombinant Vaccine nonavalent × Clear all
NCT05087849 2025-10-02

Intralesional HPV Vaccine for Condylomata

University of California, San Francisco

Phase 1/2 Completed
2 enrolled 7 charts

Condylomata Acuminata, Warts

NCT05496231 2025-02-03

A Study on the Immune Response and Safety of an Adjuvanted Human Papillomavirus Vaccine When Given to Healthy Women 16 to 26 Years of Age

GlaxoSmithKline

Phase 1/2 Completed
1,080 enrolled 28 charts
Gynecologic

Uterine Cervical Dysplasia, Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡